A spokesperson for AstraZeneca, a front-runner in the clinical-trials race, declined to comment on the case of a volunteer in Brazil participating in its study citing “medical confidentiality and clinical trial regulations.”
A spokesperson for AstraZeneca, a front-runner in the clinical-trials race, declined to comment on the case of a volunteer in Brazil participating in its study citing “medical confidentiality and clinical trial regulations.”
